Last updated on November 2019

RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2D and CKD


Brief description of study

Kidney function in patients with atrial fibrillation (AF) is tending to decline over a time which is clearly demonstrated in clinical studies. Taking into account that renal impairment is a risk factor for stroke and its progression is associated with unfavorable prognosis it's clear that preserving kidney function should be considered as a one of priorities when choosing treatment strategies which is especially important in patients with existing chronic kidney disease or in patients who are under risk of its development. This is especially relevant for the patients with Diabetes mellitus and with Chronic kidney disease who can be considered as a group of risk of rapid progression of kidney function decline.

Clinical Study Identifier: NCT03789695

Find a site near you

Start Over